An update from AIM Vaccine Co., Ltd. Class H ( ($HK:6660) ) is now available. AIM Vaccine Co., Ltd. announced the strategic integration of ...

As public skepticism toward mRNA vaccines grows, lawmakers in several states are taking decisive action to protect their constituents from what they deem potential risks associated with these ...

Currently, the most widely used vaccine against TB is the Bacillus Calmette-Guérin (BCG). Developed in 1921, the vaccine ...

The plant-editing system uses mRNA to avoid the risk that foreign DNA could be left behind and create unwanted mutations.